Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 20, 2020 - Issue 8
Submit an article Journal homepage
583
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluation

Toripalimab for the treatment of melanoma

Bixia TangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, ChinaView further author information
,
Zhihong ChiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, ChinaCorrespondence[email protected]
View further author information
&
Jun GuoKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, ChinaCorrespondence[email protected]
View further author information
Pages 863-869 | Received 30 Dec 2019, Accepted 27 Apr 2020, Published online: 14 May 2020

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mengzhen Jiang, Man Liu, Guodi Liu, Jiawen Ma, Lixin Zhang & Shenlin Wang. (2023) Advances in the structural characterization of complexes of therapeutic antibodies with PD-1 or PD-L1. mAbs 15:1.
Read now

Articles from other publishers (12)

Jing Yang, Ji Yang & Yuan‐Jia Hu. (2023) Characteristics of clinical trials of new oncology drugs approved in China. Cancer.
Crossref
Zeming Mo, Jie Liu, Jinyan Zhang, Yaotiao Deng, Miao Xu & Yu Jiang. (2023) Association of NRAS mutations and tertiary lymphoid structure formation with clinical outcomes of adjuvant PD-1 inhibitors for acral melanoma. International Immunopharmacology 124, pages 110973.
Crossref
Xiaoyan Chen & Wenjie Shi. (2023) An unusual case of immune-related gastritis in one patient receiving toripalimab therapy. Immunotherapy 15:5, pages 335-342.
Crossref
Chuanliang Cui, Yu Chen, Zhiguo Luo, Zhengyun Zou, Yu Jiang, Hongming Pan, Qingxia Fan, Jianfu Zhao, Qing Xu, Renbing Jiang, Xuan Wang, Taiyang Ma, Zhen Guo, Lu Si, Zhihong Chi, Xinan Sheng, Yiwei Dou, Qian Tan, Di Wu & Jun Guo. (2023) Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study. BMC Cancer 23:1.
Crossref
B. Lian, L. Si, Z.H. Chi, X.N. Sheng, Y. Kong, X. Wang, H. Tian, K. Li, L.L. Mao, X. Bai, B.X. Tang, X.Q. Yan, S.M. Li, L. Zhou, J. Dai, X.W. Tang, F.W. Ran, S. Yao, J. Guo & C.L. Cui. (2022) Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial. Annals of Oncology 33:10, pages 1061-1070.
Crossref
Meiqi Li, Xianmei Zhong, Fukuan Du, Xu Wu, Mingxing Li, Yu Chen, Yueshui Zhao, Jing Shen, Zhongming Yang & Zhangang Xiao. (2022) Current Understanding and Future Perspectives on Hyperprogressive Disease Highlight the Tumor Microenvironment. The Journal of Clinical Pharmacology 62:9, pages 1059-1078.
Crossref
Wei Pan, Li Yin, Yadi Guo, Dachao Pan & Hui Huang. (2022) Case Report: Good cardiac tolerance to Toripalimab in a CVD patient with oral melanoma. Frontiers in Pharmacology 13.
Crossref
Cao-Jie Chen, Hiroki Kajita, Noriko Aramaki-Hattori, Shigeki Sakai & Kazuo Kishi. (2022) Screening of Autophagy-Related Prognostic Genes in Metastatic Skin Melanoma. Disease Markers 2022, pages 1-17.
Crossref
Lin Zhang, Bo Hao, Zhihua Geng & Qing Geng. (2022) Toripalimab: the First Domestic Anti-Tumor PD-1 Antibody in China. Frontiers in Immunology 12.
Crossref
Quan Liu, Wei Cui, Chao Yang & Li-Ping Du. (2021) Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma. Aging 13:15, pages 19822-19834.
Crossref
Qingyue Zheng, Jiarui Li, Hanlin Zhang, Yuanzhuo Wang & Shu Zhang. (2020) Immune Checkpoint Inhibitors in Advanced Acral Melanoma: A Systematic Review. Frontiers in Oncology 10.
Crossref
Chuanliang Cui, Yu Chen, Zhiguo Luo, Zhengyun Zou, Yu Jiang, Hongming Pan, Qingxia Fan, Jianfu Zhao, Qing Xu, Renbing Jiang, Xuan Wang, Taiyang Ma, Zhen Guo, Lu Si, Zhihong Chi, Xinan Sheng, Yiwei Dou, Qian Tan, Di Wu & Jun Guo. (2022) Safety and Efficacy of Pucotenlimab (HX008) - A Humanized Immunoglobulin G4 Monoclonal Antibody in Patients with Locally Advanced or Metastatic Melanoma: A Single-Arm, Multicenter, Phase II Study. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.